Nicole R. Infarinato

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Nicole R. Infarinato, Jin H. Park, Kateryna Krytska et al. · Cancer Discovery · 2015 · 180 citations · Full text

Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories

Kevin Andrew Uy Gonzales, Lisa Polak, Irina Matos et al. · Science · 2021 · 129 citations · Full text

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

Kateryna Krytska, Hannah T. Ryles, Renata Sano et al. · Clinical Cancer Research · 2015 · 105 citations · Full text

Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma

Andrew Wood, Kateryna Krytska, Hannah T. Ryles et al. · Clinical Cancer Research · 2016 · 94 citations · Full text

NFI transcription factors provide chromatin access to maintain stem cell identity while preventing unintended lineage fate choices

Rene C. Adam, Hanseul Yang, Yejing Ge et al. · Nature Cell Biology · 2020 · 88 citations · Full text

Chromatin, Lineage Plasticity, Chromatin Access +13